lens dose

透镜剂量
  • 文章类型: Journal Article
    确定脊柱外科医生在脊髓造影期间接受的眼晶状体剂量(3mm剂量当量[Hp(3)]),并评估防辐射眼镜和X射线管系统定位在减少辐射暴露方面的有效性。这项研究包括使用台式或台式X射线管系统进行脊髓造影的脊柱外科医生。使用安装在防辐射玻璃上的放射性光致发光玻璃剂量计(GD-352M)测量每次检查的Hp(3)。这项研究确定了显著高的Hp(3)水平,尤其是在脊柱外科医生的右眼晶状体中。对于表上和表下的X射线管系统,右眼的中位Hp(3)值分别为524(391-719)和58(42-83)μSv/检查,分别。Further,Hp(3)AK,它是通过将累积空气角值除以Hp(3)获得的,对于表上和表下的X射线管系统,分别为8.09(6.69-10.21)和5.11(4.06-6.31)μSvmGy-1,分别。实施防辐射眼镜的剂量减少率分别为54%(50%-57%)和54%(51%-60%)的表上下X射线管系统,分别。辐射防护眼镜的使用显着减少了脊髓造影期间眼睛晶状体中的辐射剂量,最有效的措施是结合使用辐射防护眼镜和台下X射线管系统。
    To determine the eye lens dose (3 mm dose equivalent [Hp(3)]) received by spine surgeons during myelography and evaluate the effectiveness of radiation-protective glasses and x-ray tube system positioning in reducing radiation exposure. This study included spine surgeons who performed myelography using over- or under-table x-ray tube systems. Hp(3) was measured for each examination using a radio-photoluminescence glass dosimeter (GD-352M) mounted on radiation-protective glass. This study identified significantly high Hp(3) levels, especially in the right eye lens in spinal surgeons. The median Hp(3) values in the right eye were 524 (391-719) and 58 (42-83)μSv/examination for over- and under-table x-ray tube systems, respectively. Further, Hp(3)AK, which was obtained by dividing the cumulative air kerma from Hp(3), was 8.09 (6.69-10.21) and 5.11 (4.06-6.31)μSv mGy-1for the over- and under-table x-ray tube systems, respectively. Implementing radiation-protective glasses resulted in dose reduction rates of 54% (50%-57%) and 54% (51%-60%) for the over- and under-table x-ray tube systems, respectively. The use of radiation protection glasses significantly reduced the radiation dose in the eye lens during myelography, with the most effective measures being the combination of using radiation protection glasses and an under-table x-ray tube system.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:本研究报告了金涂层隐形眼镜型眼体内剂量计(CLOD)在计算机断层扫描(CT)中低剂量测量的敏感性增强。
    方法:进行蒙特卡罗(MC)模拟以评估CLOD上的金(Au)层的剂量增强。对人眼和CLODs进行了建模,并且X射线管电压被定义为80、120和140kVp。附着于CLOD的Au层的厚度为100nm至10μm。活性层的厚度为20至140μm。Au涂覆的CLOD的活性层与没有层的CLOD之间的剂量比,即,剂量增强因子(DEF),已计算。
    结果:在80、120和140kVp下,5μm厚的Au涂层CLOD的第一个20μm厚的活性层的DEF分别为18.4、19.7、20.2,分别。DEF随着活性层厚度的增加而降低。当活性层的厚度为140μm时,对于120kVpX射线管电压,100nm至5μm厚的Au层的DEF从1.7增加到5.4。
    结论:MC结果显示,Au涂层的CLODs具有更高的灵敏度(比没有金层的CLODs高出约20倍)。Au涂层的CLODs可用于评估在CT成像期间递送至患者的极低剂量(几个cGy)。
    OBJECTIVE: This study reports a sensitivity enhancement of gold-coated contact lens-type ocular in vivo dosimeters (CLODs) for low-dose measurements in computed tomography (CT).
    METHODS: Monte Carlo (MC) simulations were conducted to evaluate the dose enhancement from the gold (Au) layers on the CLODs. The human eye and CLODs were modeled, and the X-ray tube voltages were defined as 80, 120, and 140 kVp. The thickness of the Au layer attached to a CLOD ranged from 100 nm to 10 μm. The thickness of the active layer ranged from 20 to 140 μm. The dose ratio between the active layer of the Au-coated CLOD and a CLOD without a layer, i.e., the dose enhancement factor (DEF), was calculated.
    RESULTS: The DEFs of the first 20-μm thick active layer of the 5-μm thick Au-coated CLOD were 18.4, 19.7, 20.2 at 80, 120, and 140 kVp, respectively. The DEFs decreased as the thickness of the active layer increased. The DEFs of 100-nm to 5-μm thick Au layers increased from 1.7 to 5.4 for 120-kVp X-ray tube voltage when the thickness of the active layer was 140 μm.
    CONCLUSIONS: The MC results presented a higher sensitivity of Au-coated CLODs (∼20-times higher than that of CLODs without a gold layer). Au-coated CLODs can be applied to an evaluation of very low doses (a few cGy) delivered to patients during CT imaging.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号